BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6989492)

  • 1. Mechanism of deoxycytidine rescue of thymidine toxicity in human T-leukemic lymphocytes.
    Fox RM; Tripp EH; Tattersall MH
    Cancer Res; 1980 May; 40(5):1718-21. PubMed ID: 6989492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ; Otten M; Grindey GB
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Törnevik Y; Eriksson S
    Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
    Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
    Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,6-Diaminopurinedeoxyriboside as a prodrug of deoxyguanosine in L1210 cells.
    Weckbecker G; Cory JG
    Cancer Res; 1987 May; 47(9):2218-23. PubMed ID: 3552212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyribonucleotide pools in mouse-fibroblast cell lines with altered ribonucleotide reductase.
    Meuth M; Aufreiter E; Reichard P
    Eur J Biochem; 1976 Dec; 71(1):39-43. PubMed ID: 1087605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of specific correlation of the deoxycytidine triphosphate pool level with rate of DNA synthesis.
    Walters RA; Ratliff RL
    Biochim Biophys Acta; 1975 Dec; 414(3):221-30. PubMed ID: 1203255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine.
    Dahbo Y; Eriksson S
    Eur J Biochem; 1985 Aug; 150(3):429-34. PubMed ID: 3874778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
    Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
    Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleoside triphosphate pools and differential thymidine sensitivities of cultured mouse lymphoma and myeloma cells.
    Reynolds EC; Harris AW; Finch LR
    Biochim Biophys Acta; 1979 Jan; 561(1):110-23. PubMed ID: 570417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of leukemic human null lymphocytes to deoxynucleosides.
    Fox RM; Tripp EH; Piddington SK; Tattersall MH
    Cancer Res; 1980 Sep; 40(9):3383-6. PubMed ID: 6253063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyribonucleoside triphosphate pools and thymidine chemosensitization in human T-cell leukemia.
    Cohen JD; Robins HI; Katz TB; Miller EM; Kuzminsky SR; Javid MJ
    Leuk Res; 1993 Feb; 17(2):167-74. PubMed ID: 8429693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth.
    Slabaugh MB; Howell ML; Wang Y; Mathews CK
    J Virol; 1991 May; 65(5):2290-8. PubMed ID: 2016760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of thymidine on deoxyribonucleotide pool levels, cytotoxicity and mutation induction in Friend mouse erythroleukaemia cells.
    Wilkinson YA; McKenna PG
    Leuk Res; 1989; 13(7):615-20. PubMed ID: 2761292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777.
    Bantia S; Ananth SL; Parker CD; Horn LL; Upshaw R
    Int Immunopharmacol; 2003 Jun; 3(6):879-87. PubMed ID: 12781704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.